Also trades as: CDT (NASDAQ) · $vol 2M
CDTTW NASDAQ
CDT Equity Inc.
1W: -8.6%
1M: +18.2%
3M: +77.3%
YTD: +91.8%
1Y: -20.9%
$0.01
-0.00 (-0.85%)
Weekly Expected Move ±27.5%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
26 relationships26
As Filer
counterparties named
0
As Counterparty
mentioned by others
6
Rel. Types
2022-02-08
Earliest Filing
2026-03-09
Latest Filing
acquirer: 8
target: 7
partner: 6
customer: 3
investor: 1
supplier: 1
Counterparties (Filed by CDTTW)
26 relationshipsCompanies named in CDTTW's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Ascent Partners Fund LLC | — | acquirer | Purchaser amending the Directed Stock Purchase Agreement | 2026-03-09 | View |
| CDT Equity Inc. | CDTTW | target | Company entering into an amendment to a Directed Stock Purchase Agreement | 2026-03-09 | View |
| CDT Equity Inc. | CDTTW | acquirer | Company issuing common stock and pre-funded warrants in exchange for Sarborg Limited shares and cash consideration. | 2026-02-24 | View |
| Sarborg Limited | — | target | Company whose shares are being acquired by CDT Equity Inc. in exchange for cash and warrants. | 2026-02-24 | View |
| Ascent Partners Fund LLC | — | investor | Purchaser acquiring securities from the Company | 2026-01-22 | View |
| CDT Equity Inc. | CDTTW | acquirer | Company issuing and selling securities to the Purchaser | 2026-01-22 | View |
| Corvus Capital Limited | — | acquirer | Acquired CPL Shares from CDT Equity Inc. in exchange for settlement shares and warrants. | 2025-12-12 | View |
| CDT Equity Inc. | CDTTW | target | Sold CPL Shares to Corvus Capital Limited to remove liability from the Strand Litigation. | 2025-12-12 | View |
| Conduit Pharmaceuticals Limited | — | target | Wholly-owned subsidiary of CDT Equity Inc. whose shares were the subject of the sale. | 2025-12-12 | View |
| Strand Hanson Limited | SWAGW | partner | Entity involved in the Strand Litigation against CPL; subject of the indemnification agreement. | 2025-12-12 | View |
| Conduit Pharmaceuticals Inc. | CDT | partner | Partner entering into a Joint Development Agreement for animal health indications. | 2025-06-09 | View |
| Manoira Corporation | — | partner | Partner entering into a Joint Development Agreement for animal health indications. | 2025-06-09 | View |
| Sarborg Limited | — | partner | Licensee providing proprietary algorithms for clinical data analysis of AstraZeneca assets | 2025-04-04 | View |
| SARBORG Limited | — | supplier | Provider of algorithmic and cybernetic decision-support tools and services | 2024-12-17 | View |
| Conduit Pharmaceuticals Inc. | — | customer | Clinical-stage life science company engaging Sarborg for decision-making enhancement services | 2024-12-17 | View |
| Conduit Pharmaceuticals Inc. | — | partner | Issuer of the convertible promissory note | 2024-11-25 | View |
| Conduit Pharmaceuticals Inc. | — | customer | Borrower in a bridge loan agreement | 2024-11-01 | View |
| Murphy Canyon Acquisition Corp. | — | acquirer | Target company for business combination and potential stock conversion | 2024-10-15 | View |
| Conduit Pharmaceuticals Limited | — | customer | Issuer of the convertible promissory note | 2024-10-15 | View |
| AstraZeneca | AZN | partner | Conduit Pharmaceuticals enters into exclusive license agreement with AstraZeneca for multiple assets to advance potentia | 2024-08-08 | View |
| Conduit Merger Sub, Inc. | — | target | Merger subsidiary of Conduit Pharmaceuticals | 2023-05-11 | View |
| Conduit Pharmaceuticals Limited | — | target | Target company in the merger transaction | 2023-05-11 | View |
| Murphy Canyon Acquisition Corp. | — | acquirer | Acquirer in the merger transaction | 2023-05-11 | View |
| Murphy Canyon Acquisition Corp. | — | acquirer | Issuer of the promissory note | 2023-03-08 | View |
| Murphy Canyon Acquisition Corp. | — | target | Company issuing securities in the offering | 2022-02-08 | View |
| A.G.P./Alliance Global Partners | — | acquirer | Representative of the underwriters | 2022-02-08 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-25 | Bylaws Amendment; Regulation FD; Exhibits | View | |
| 2026-09-18 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-09-04 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-09-01 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-09-01 | Other Events | View | |
| 2026-08-21 | Exhibits | View | |
| 2026-08-21 | Acquisition/Disposition; Exhibits | Acquisition | View |
| 2026-08-06 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-08-03 | Acquisition/Disposition; Exhibits | Acquisition | View |
| 2026-07-31 | Material Agreement; Unregistered Equity Sales; Exhibits | Agreement | View |
| 2026-07-29 | Unregistered Equity Sales | View | |
| 2026-07-16 | Bylaws Amendment; Regulation FD; Exhibits | View | |
| 2026-07-07 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-06-29 | Accountant Change; Exhibits | View | |
| 2026-06-16 | Material Agreement; Financial Obligation; Unregistered Equity Sales; Other Events; Exhibits | Agreement | View |
| 2026-05-28 | Delisting Notice; Regulation FD; Exhibits | View | |
| 2026-04-27 | Officer/Director Change | View | |
| 2026-03-25 | Bylaws Amendment; Regulation FD; Exhibits | View | |
| 2026-03-09 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2026-02-24 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR